Problems with evidence assessment in COVID-19 health policy impact evaluation: A systematic review of study design and evidence strength
COVID-19; health policy; statistics &; research methods
Introduction Assessing the impact of COVID-19 policy is critical for informing future policies. However, there are concerns about the overall strength of COVID-19 impact evaluation studies given the circumstances for evaluation and concerns about the publication environment. Methods We included studies that were primarily designed to estimate the quantitative impact of one or more implemented COVID-19 policies on direct SARS-CoV-2 and COVID-19 outcomes. After searching PubMed for peer-reviewed articles published on 26 November 2020 or earlier and screening, all studies were reviewed by three reviewers first independently and then to consensus. The review tool was based on previously developed and released review guidance for COVID-19 policy impact evaluation. Results After 102 articles were identified as potentially meeting inclusion criteria, we identified 36 published articles that evaluated the quantitative impact of COVID-19 policies on direct COVID-19 outcomes. Nine studies were set aside because the study design was considered inappropriate for COVID-19 policy impact evaluation (n=8 pre/post; n=1 cross-sectional), and 27 articles were given a full consensus assessment. 20/27 met criteria for graphical display of data, 5/27 for functional form, 19/27 for timing between policy implementation and impact, and only 3/27 for concurrent changes to the outcomes. Only 4/27 were rated as overall appropriate. Including the 9 studies set aside, reviewers found that only four of the 36 identified published and peer-reviewed health policy impact evaluation studies passed a set of key design checks for identifying the causal impact of policies on COVID-19 outcomes. Discussion The reviewed literature directly evaluating the impact of COVID-19 policies largely failed to meet key design criteria for inference of sufficient rigour to be actionable by policy-makers. More reliable evidence review is needed to both identify and produce policy-actionable evidence, alongside the recognition that actionable evidence is often unlikely to be feasible.
Haber, Noah A.; Clarke-Deelder, Emma; Feller, Avi; Smith, Emily R.; Salomon, Joshua A.; MacCormack-Gelles, Benjamin; Stone, Elizabeth M.; Bolster-Foucault, Clara; Daw, Jamie R.; Hatfield, Laura Anne; Fry, Carrie E.; Boyer, Christopher B.; Ben-Michael, Eli; Joyce, Caroline M.; Linas, Beth S.; Schmid, Ian; Au, Eric H.; Wieten, Sarah E.; Jarrett, Brooke; Axfors, Cathrine; Nguyen, Van Thu; Griffin, Beth Ann; Bilinski, Alyssa; and Stuart, Elizabeth A., "Problems with evidence assessment in COVID-19 health policy impact evaluation: A systematic review of study design and evidence strength" (2022). GW Authored Works. Paper 42.